Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 1;11(3):212-223.
doi: 10.1093/jmcb/mjy077.

Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53

Affiliations

Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53

Elizabeth Lieschke et al. J Mol Cell Biol. .

Abstract

Activation of the tumour suppressor p53 upon cellular stress can induce a number of different cellular processes. The diverse actions of these processes are critical for the protective function of p53 in preventing the development of cancer. However, it is still not fully understood which process(es) activated by p53 is/are critical for tumour suppression and how this might differ depending on the type of cells undergoing neoplastic transformation and the nature of the drivers of oncogenesis. Moreover, it is not clear why upon activation of p53 some cells undergo cell cycle arrest and senescence whereas others die by apoptosis. Here we discuss some of the cellular processes that are crucial for p53-mediated tumour suppression and the factors that could impact cell fate upon p53 activation. Finally, we describe therapies aimed either at activating wild-type p53 or at changing the behaviour of mutant p53 to unleash tumour growth suppressive processes for therapeutic benefit in malignant disease.

Keywords: cell cycle arrest/senescence; cell death; p53; tumour suppression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cellular processes that are impacted by p53 activation, listing some important genes that regulate these pathways. Diverse stresses activate p53 via a number of upstream signalling pathways that are not depicted here. Upon activation, p53 impacts several cellular processes through direct (bold) and/or indirect (underlined) regulation of target genes. Genes that are induced by p53 are shown in black, whereas genes that are repressed by p53 are in blue. The processes activated by p53 that are postulated to contribute to its ability to suppress tumour development include apoptosis, cell cycle arrest, cellular senescence, DNA repair, regulation of cellular metabolism, autophagy, and ferroptotic cell death.
Figure 2
Figure 2
p53 regulation of the apoptotic cell death pathways. Cell death regulators encoded by direct p53 target genes and transcriptionally induced are outlined in a solid red box; those encoded by indirect p53 target genes and induced are outlined in a dashed red box; those encoded by indirect p53 target genes and repressed are outlined in a dashed blue box; other cell death regulators (not controlled by p53) are outlined in grey.

Similar articles

Cited by

References

    1. Alexandrova E.M., Mirza S.A., Xu S., et al. . (2017). p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo. Cell Death Dis. 8, e2661. - PMC - PubMed
    1. Alexandrova E.M., Yallowitz A.R., Li D., et al. . (2015). Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature 523, 352–356. - PMC - PubMed
    1. Allen M.A., Andrysik Z., Dengler V.L., et al. . (2014). Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. eLife 3, e02200. - PMC - PubMed
    1. Althubiti M., Lezina L., Carrera S., et al. . (2014). Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis. 5, e1528. - PMC - PubMed
    1. Aubrey B.J., Janic A., Chen Y.A., et al. . (2018). Mutant TRP53 exerts a target gene selective dominant negative effect to drive tumor development. Genes Dev. 32, 1420–1429. - PMC - PubMed

Publication types

MeSH terms

Substances